Konect-DP Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg, Paracetamol 325 mg, and Trypsin Chymotrypsin 50,000 AU. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides effective analgesia and antipyresis through central inhibition of prostaglandin synthesis, complementing Diclofenac’s peripheral action. Trypsin Chymotrypsin, a proteolytic enzyme complex, facilitates the reduction of inflammation and edema by promoting proteolytic degradation of inflammatory mediators and fibrin deposits, enhancing tissue repair and recovery. Konect-DP is indicated for the management of acute musculoskeletal pain, postoperative inflammation, soft tissue injuries, and inflammatory conditions such as arthritis. The synergistic combination offers rapid and sustained relief from pain and inflammation while supporting tissue healing. It is recommended to be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, bleeding disorders, and severe hepatic or renal impairment. Caution is advised in patients with cardiovascular risk factors. Adverse effects may include gastrointestinal discomfort, allergic reactions, and rare hepatic or renal dysfunction. Dosage should be individualized based on clinical response and patient tolerance.